生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
MG-63(RCB1890)
,
143B/TK^(-)neo^(R)(RCB0701)
|
74525
|
Compound Library Screening for Synergistic Drug Combinations: mTOR Inhibitor and Proteasome Inhibitor Effective Against Osteosarcoma Cells.
|
Anticancer Res |
2022-9-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
TUHR10TKB(RCB1275)
,
OS-RC-2(RCB0735)
,
RCC10RGB(RCB1151)
|
69911
|
The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma.
|
PLoS One |
2021-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
,
SSP-25(RCB1293)
,
RBE(RCB1292)
,
YSCCC(RCB1549)
,
TGBC24TKB(RCB1196)
,
TFK-1(RCB2537)
|
67146
|
Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
|
Dis Model Mech |
2018-5-14 |
Pubmed
Full text
|
ヒト・動物細胞
|
JHOC-7(RCB1688)
,
JHOC-9(RCB2226)
|
63551
|
Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.
|
Cancer Sci |
2020-10-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
TKKK(RCB1907)
,
TGBC2TKB(RCB1130)
,
TGBC18TKB(RCB1169)
,
TGBC14TKB(RCB1186)
,
G-415(RCB2640)
,
HuCCT1(RCB1960)
|
61781
|
K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.
|
Mol Oncol |
2017-9-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
RBE(RCB1292)
,
YSCCC(RCB1549)
|
52513
|
Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
|
Oncol Rep |
2018-2-1 |
Pubmed
Full text
|